Cargando…
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
BACKGROUND: Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant chemotherapy for resected colon cancer (CC) reduces cancer recurrence, but also causes significant toxicity requiring dose reductions. The effect of dose inten...
Autores principales: | Breadner, Daniel, Loree, Jonathan M., Cheung, Winson Y., Gipson, Meghan, Lakkunarajah, Suganija, Mulder, Karen E., Spartlin, Jennifer L., Kong, Shiying, Ding, Philip Q., Gill, Sharlene, Welch, Stephen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628061/ https://www.ncbi.nlm.nih.gov/pubmed/36319973 http://dx.doi.org/10.1186/s12885-022-10198-y |
Ejemplares similares
-
The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective Analysis
por: Lakkunarajah, Suganija, et al.
Publicado: (2021) -
Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies
por: Gill, Sharlene
Publicado: (2014) -
Association of a Shortened Duration of Adjuvant Chemotherapy With Overall Survival Among Individuals With Stage III Colon Cancer
por: Boyne, Devon J., et al.
Publicado: (2021) -
Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer
por: Preti, Beatrice T. B., et al.
Publicado: (2023) -
Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting
por: Loree, Jonathan, et al.
Publicado: (2021)